Skip to main content

Table 1 Maternal characteristics and biochemical data

From: Alterations of gut microbiota in gestational diabetes patients during the second trimester of pregnancy in the Shanghai Han population

Maternal characteristics and biochemical variables GDM (n = 21) Control (n = 32) P value
Age (years) 28.7 ± 3.42 31.5 ± 4.56 0.019*
Pre-BMI (kg/m2) 21.7 (19.96–23.47) 22.6 (18.95–25.25) 0.94
Gestational age (weeks) 25.3 (25–26) 25.6 (25–26) 0.32
Fasting glucose (mmol/L) 5.0 ± 0.43 4.7 ± 0.23 < 0.01**
1 h glucose (mmol/L) 9.15 (8.18–10.25) 7.35 (6.13–8.77) < 0.01**
2 h glucose (mmol/L) 7.27 (6.51–8.08) 6.33 (5.77–7.29) 0.024*
Hb1AC (%) 5.01 (4.85–5.1) 4.84 (4.5–5.1) 0.091*
Fasting insulin (μU/L) 58.07 (40.1–66.4) 46.94 (32.45–47.58) 0.016*
1 h insulin (μU/L) 573.3 (301.6–728.4) 359.27 (198.1–480.2) 0.016*
2 h insulin (μU/L) 383.31 (183.1–574.8) 301.55 (199.2–368.0) 0.363
HOMA-IR 1.88 (1.25–2.25) 1.41 (0.91–1.43) 0.008**
Triglyceride (mmol/L) 2.31 ± 0.68 2.62 ± 0.82 0.171
Total cholesterol (mmol/L) 6.02 ± 1.14 6.11 ± 0.82 0.741
HDL (mmol/L) 1.86 ± 0.38 2.0 ± 0.39 0.199
LDL (mmol/L) 2.99 ± 0.79 2.97 ± 0.73 0.926
  1. Clinical characteristics, biochemical and hormonal variables of GDM and normoglycemic pregnant women at 24–28 weeks gestation are presented as mean ± SEM when normally distributed or median with 25–75th interquartile range when non-normal distributed. Statistically significant difference between the GDM and normoglycemic women group are highlighted (* P < 0.05, ** P < 0.01). HOMA-IR, HOMA-IR = FPG (mmol/L), FINS(μU/mL)/22.5